Alteration of the tumor suppressor gene p53 in a high fraction of hormone refractory prostate cancer.
Data up to Jan 2025
Total Citations Per Year
Abstract
References (35)
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
1990 • 3,720 citations
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
1994 • 3,536 citations
WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis.
1994 • 2,025 citations
Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li–Fraumeni syndrome
1990 • 1,228 citations
Cancer statistics, 1993
1993 • 983 citations
Accumulation of Nuclear p53 and Tumor Progression in Bladder Cancer
1994 • 828 citations
Urologic pathology: The prostate
1977 • 821 citations
p53 Protein Accumulation and Gene Mutation in the Progression of Human Prostate Carcinoma
1993 • 488 citations
Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles.
1991 • 440 citations
p53 is mutated in a subset of advanced-stage prostate cancers.
1993 • 377 citations
Frequent detection of codon 877 mutation in the androgen receptor gene in advanced prostate cancers.
1994 • 364 citations
Identification of a minimal transforming domain of p53: negative dominance through abrogation of sequence-specific DNA binding.
1992 • 344 citations
‘Cold SSCP’: a simple, rapid and non-radioactive method for optimized single-strand conformation polymorphism analyses
1993 • 335 citations
Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 Accumulation
1992 • 317 citations
Association of P53 Nuclear Overexpression and Tumor Progression in Carcinoma in situ of the Bladder
1994 • 221 citations
Cell proliferation, DNA repair, and p53 function are not required for programmed death of prostatic glandular cells induced by androgen ablation.
1993 • 201 citations
p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate
1992 • 169 citations
Grading of prostatic carcinoma.
1975 • 151 citations
P53 Oncogene Mutations in Human Prostate Cancer Specimens
1994 • 125 citations
Immunohistochemical Determination of P53 Protein Nuclear Accumulation in Prostatic Adenocarcinoma
1994 • 116 citations
Alterations of The P53 Gene Are Associated With The Progression Of A Human Prostate Carcinoma
1992 • 107 citations
Histological Typing of Prostate Tumours
2002 • 107 citations
P53 Gene Alterations in Human Prostate Carcinoma
1993 • 106 citations
Infrequent RAS oncogene mutations in human prostate cancer
1992 • 93 citations
Cancer risks from germline p53 mutations.
1992 • 89 citations
p53 Expression and Clinical Outcome in Prostate Cancer
1993 • 79 citations
Mutant p53 expression in prostate carcinoma
1993 • 77 citations
Comparative analysis ofp53 protein immunoreactivity in prostatic, lung and breast carcinomas
1992 • 62 citations
Dominant negative effect of a germ-line mutant p53: a step fostering tumorigenesis.
1993 • 56 citations
p53 and c-myc Expression in Stage A1 Prostatic Adenocarcinoma: Useful Prognostic Determinants?
1993 • 55 citations
Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
1992 • 48 citations
Infrequent involvement of p53 gene mutations in the tumourigenesis of Japanese prostate cancer
1993 • 35 citations
Enhanced Expression of p53 mRNA and Protein in the Regressing Rat Ventral Prostate Gland
1994 • 27 citations
New Prognostic Factors in Prostatic Carcinoma
1993 • 27 citations
Update in Staging Systems
1987 • 8 citations
Cited By (0)
No citing papers found in database